A detailed history of Auxano Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Auxano Advisors, LLC holds 30,014 shares of NVO stock, worth $2.62 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
30,014
Previous 30,027 0.04%
Holding current value
$2.62 Million
Previous $4.29 Million 16.64%
% of portfolio
0.97%
Previous 1.23%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$119.07 - $145.42 $1,547 - $1,890
-13 Reduced 0.04%
30,014 $3.57 Million
Q2 2024

Jul 31, 2024

SELL
$122.71 - $146.91 $25,523 - $30,557
-208 Reduced 0.69%
30,027 $4.29 Million
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $59,938 - $79,785
587 Added 1.98%
30,235 $3.88 Million
Q4 2023

Feb 05, 2024

SELL
$87.78 - $105.45 $15,800 - $18,981
-180 Reduced 0.6%
29,648 $3.07 Million
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $290,371 - $637,131
3,193 Added 11.99%
29,828 $2.71 Million
Q1 2023

Apr 27, 2023

SELL
$132.34 - $159.14 $153,646 - $184,761
-1,161 Reduced 4.18%
26,635 $4.24 Million
Q4 2022

Feb 03, 2023

BUY
$102.55 - $135.33 $7,896 - $10,420
77 Added 0.28%
27,796 $3.76 Million
Q3 2022

Nov 02, 2022

BUY
$95.28 - $116.93 $189,130 - $232,106
1,985 Added 7.71%
27,719 $2.76 Million
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $71,545 - $84,414
693 Added 2.77%
25,734 $2.87 Million
Q1 2022

May 06, 2022

BUY
$93.1 - $112.54 $12,661 - $15,305
136 Added 0.55%
25,041 $2.78 Million
Q4 2021

Feb 04, 2022

BUY
$95.88 - $117.08 $5,561 - $6,790
58 Added 0.23%
24,905 $2.79 Million
Q3 2021

Nov 03, 2021

SELL
$84.42 - $106.62 $38,157 - $48,192
-452 Reduced 1.79%
24,847 $2.39 Million
Q2 2021

Aug 06, 2021

BUY
$67.66 - $84.76 $17,862 - $22,376
264 Added 1.05%
25,299 $2.12 Million
Q1 2021

Apr 29, 2021

BUY
$67.06 - $75.82 $47,880 - $54,135
714 Added 2.94%
25,035 $1.69 Million
Q4 2020

Feb 11, 2021

BUY
$63.89 - $73.8 $73,601 - $85,017
1,152 Added 4.97%
24,321 $1.7 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $78,529 - $86,581
1,233 Added 5.62%
23,169 $1.61 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $10,244 - $11,889
175 Added 0.8%
21,936 $1.44 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $1.08 Million - $1.41 Million
21,761 New
21,761 $1.31 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Auxano Advisors, LLC Portfolio

Follow Auxano Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxano Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auxano Advisors, LLC with notifications on news.